NASDAQ · EVGN
EVOGENE financials
$0.4100+7.89%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.9M | $5.6M | $3.0M | $1.7M | $930.0K | $1.0M | $753.0K | $1.7M | $3.4M | $6.5M |
| Gross profit | -$241.0K | $3.2M | $1.5M | $766.0K | $163.0K | $466.0K | $419.0K | $295.0K | $536.0K | $901.0K |
| Gross margin | −6.3% | 57.3% | 50.0% | 45.7% | 17.5% | 44.8% | 55.6% | 16.9% | 15.9% | 13.8% |
| Operating income | -$14.0M | -$18.8M | -$22.2M | -$30.4M | -$31.0M | -$24.8M | -$21.2M | -$20.0M | -$21.9M | -$21.1M |
| Net income | -$8.5M | -$16.5M | -$23.9M | -$26.6M | -$27.8M | -$23.4M | -$18.1M | -$20.8M | -$20.8M | -$19.6M |
| Net margin | −220.2% | −295.6% | −800.8% | −1590.3% | −2988.5% | −2247.5% | −2405.3% | −1188.2% | −616.3% | −299.6% |
| Diluted EPS | $-1.08 | $-2.90 | $-5.20 | $-6.44 | $-0.69 | $-0.83 | $-0.70 | $-0.81 | $-0.81 | $-0.77 |
| EBITDA | -$12.9M | -$17.4M | -$20.9M | -$27.9M | -$28.7M | -$22.1M | -$18.4M | -$18.0M | -$19.8M | -$18.8M |
| Operating cash flow | -$13.5M | -$19.7M | -$21.6M | -$23.7M | -$24.7M | -$19.5M | -$17.7M | -$15.2M | -$15.9M | -$11.7M |
| Free cash flow | -$13.6M | -$20.3M | -$22.2M | -$24.8M | -$25.6M | -$20.2M | -$18.6M | -$15.5M | -$16.5M | -$12.5M |
| Diluted shares | 7.9M | 5.7M | 4.6M | 4.1M | 40.4M | 28.2M | 25.8M | 25.8M | 25.7M | 25.4M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $13.0M | $15.3M | $20.8M | $29.0M | $32.3M | $46.2M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $6.4M | $18.5M | $0.00 |
| Total debt | $0.00 | $10.4M | $10.4M | $10.1M | $0.00 | $0.00 |
| Total assets | $20.0M | $39.9M | $51.1M | $56.1M | $76.3M | $71.9M |
| Total liabilities | $8.1M | $25.0M | $22.4M | $21.3M | $12.9M | $15.0M |
| Shareholders' equity | $12.0M | $14.8M | $28.7M | $34.8M | $63.4M | $56.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology